Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (17014)	3/9/1998 11:55:00 PM
From: tonyt	Read Replies (1) \| Respond to of 32384

> FuGAZI, himself, supplied an answer to his own first question. Not really. There were in fact three questions (actually, there was a question, a rhetorical question and a request for comments). The first, as you pointed out was "Did LGND take the money & run, or did they select a drug?". The question, for which Fugazi supplied an answer to his own first question, the one where, as you noted appeared to be rhetorical, was " Some seemed to be confident that we'd learn of their decision this week. I guess not.", so the question to which he supplied an answer was not his own first question but his own second question, that being the question of when we'd learn of their decision, not what that decision would be. The question of what their decision would be remained unanswed, as we leaned that 'wait till Monday' had nothing to do with "Did LGND take the money & run, or did they select a drug?", but actually 'wait till Monday' was the answer to Fugazi's third question, which was not a question at all, not even a rhetorical question, but in fact was a request for comments when Fugazi stated: "AS I stated earlier, lgnd looks to be forming a base bewteen 14.5 and 15.5 range when it has never really stayed in this price zone for a long period of time. Anyone have any comments about this?", now since Ligand did indeed announce Monday after the bell that " Ligand Pharmaceuticals Incorporated announced today that Lilly has extended Ligand's option included in its collaborative arrangement in metabolic disease with Eli Lilly and Company to acquire selected rights to one Lilly specialty pharmaceutical product in certain markets of interest to Ligand.", it appears that 'wait til Monday' was indeed an answer to the first question asked by Fugazi, which was "Did LGND take the money & run, or did they select a drug?".